疏肝解郁胶囊联合艾司西酞普兰应用于老年躯体疾病焦虑抑郁患者的效果及对治疗依从性的影响

Effect of Shugan Jieyu Capsule combined with escitalopram on elderly patients with physical illness and anxiety and its effect on treatment compliance

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2019, 46(1)
作者
作者单位

河南省老干部康复医院康复病区 ;
河南省人民医院老年病科 ;

摘要
【摘要】 探讨艾司西酞普兰联合疏肝解郁胶囊应用于躯体疾病焦虑抑郁患者的效果。方法 抽签法将我院2016年10月-2018年4月收治的113例躯体疾病焦虑抑郁患者分为2组,常规治疗基础上,西药组56例予艾司西酞普兰,联合组57例加服疏肝解郁胶囊,连用2月,对比两组总有效率、神经因子水平及依从性。结果 联合组2月末总有效率、5-HT、NE、DA血清水平及检查、治疗、服药和康复锻炼依从性高于西药组,治疗2w、1月、2月末HAMA及HAMD评分及不良反应发生率低于西药组(P<0.05)。结论 疏肝解郁胶囊与艾司西酞普兰联合可改善老年躯体疾病焦虑抑郁患者神经因子水平,安全有效,患者依从性较高。
Abstract
【Abstract】 Objective To investigate the effect of escitalopram combined with Shugan Jieyu capsule on patients with somatic anxiety and depression. Methods: A total of 113 patients with physical illness and anxiety from October 2016 to April 2018 were divided into two groups. On the basis treatment, 56 patients in the western medicine group were given escitalopram and 57 in the combined group use Shugan Jieyu Capsule , the total effective rate, neurological factor level and compliance were compared after 2 months . Results After February, the total effective rate, 5-HT, NE, DA serum levels and examination, treatment, medication and rehabilitation exercise compliance were higher than the western medicine group. The HAMA and HAMD scores at the end of 2w, January and February.,the adverse reactions occurred rate were lower than the western medicine group (P<0.05). Conclusion Shugan Jieyu Capsule combined with escitalopram can improve the patients,s neurological factors level saftly and effectively, patient compliance is high.
关键词
【关键词】躯体疾病;焦虑抑郁;艾司西酞普兰;疏肝解郁胶囊;依从性
KeyWord
[Keywords] physical illness; anxiety and depression; escitalopram; Shugan Jieyu capsule; compliance
基金项目
页码 151-153
  • 参考文献
  • 相关文献
  • 引用本文

朱慧君*,柴萌萌,石宝珠,张倩. 疏肝解郁胶囊联合艾司西酞普兰应用于老年躯体疾病焦虑抑郁患者的效果及对治疗依从性的影响 [J]. 国际精神病学杂志. 2019; 46; (1). 151 - 153.

  • 文献评论

相关学者

相关机构